News

DelSiTech CEO Lasse Leino interviewed for the benefits of silica based drug delivery on PharmaTelevison

DelSiTech CEO Lasse Leino interviewed for the benefits of silica based drug delivery on PharmaTelevison

DelSiTech Ltd (info a delsitech.com), Jun 23rd 2016

DelSiTech is pleased to provide a link to an interview on PharmaTelevison where Dr. Lasse Leino, CEO of DelSiTech discusses the technology behind their biodegradable silica-based small molecule drugs, biopharmaceuticals and viral vectors. The interview can be found here:  http://pharmatelevision.com/Video/1437-PTVNRLasseLeino.aspx



Back